Differences in medical treatment of chronic coronary heart disease patients according to medical specialities

Cardiovascular Therapeutics

Volumn 27, Issue 3, 2009, Pages 173-180

  Cordero, Alberto ^a   Bertomeu Martínez, Vicente ^a   Mazón, Pilar ^b   Quiles, Juan ^a   Aznar, Joaquín ^c   Bueno, Héctor ^d  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b Hospital General de Santiago Santiago de Compostela   (Spain)

^c Hospital Nuestra Senora de Gracia   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Comorbidities; Medical treatment; Risk factors control; Specialities

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

AGED; ARTICLE; CARDIOLOGIST; CHRONIC DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OBSERVATIONAL STUDY; OUTPATIENT; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; CARDIOLOGY; CHOLESTEROL, LDL; COMORBIDITY; CORONARY DISEASE; FEMALE; HEMODYNAMICS; HUMANS; INTERNAL MEDICINE; MALE; MYOCARDIAL REVASCULARIZATION; PHYSICIANS, FAMILY; REGISTRIES; RISK FACTORS; SPAIN; SPECIALTIES, MEDICAL;

EID: 68949157064     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00093.x     Document Type: Article

References (30)

1. Roe MT, Chen AY, Mehta RH, et al. Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes. Circulation 2007 116 : 1153 1161.
2. Dewilde S, Carey IM, Richards N, Whincup PH, Cook DG. Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: Use of individual and combination treatment. Heart 2008 94 : 83 88.
3. Graham IM, Stewart M, Hertog MG. Factors impeding the implementation of cardiovascular prevention guidelines: Findings from a survey conducted by the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil 2006 13 : 839 845.
4. Heras M, Marrugat J, Aros F, et al. Reduction in Acute myocardial infarction mortality over a five-year period. Rev Esp Cardiol 2006 59 : 200 208.
5. Cubbon RM, Wheatcroft SB, Grant PJ, et al. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: A comparison of over 3000 patients between 1995 and 2003. Eur Heart J 2007 28 : 540 545.
6. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 117 : e25 146.
7. Davies AR, Smeeth L, Grundy EM. Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005. Eur Heart J 2007 28 : 2142 2147.
8. Daly C, Clemens F, Lopez-Sendon JL, et al. The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: Findings from the Euro Heart Survey of stable angina. Eur Heart J 2006 27 : 1298 1304.
9. Rogers AM, Ramanath VS, Grzybowski M, et al. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan. Am Heart J 2007 154 : 461 469.
10. Fraker TD Jr., Fihn SD, Gibbons RJ, et al. 2007 Chronic Angina Focused Updated of the ACCAHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina: A Report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina. Circulation 2007 116 : 2762 2772.
11. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007 356 : 1503 1516.
12. Frances CD, Go AS, Dauterman KW, et al. Outcome following acute myocardial infarction: Are differences among physician specialties the result of quality of care or case mix Arch Intern Med 1999 159 : 1429 1436.
13. Garcia-Castelo A, Muniz J, Sesma Sanchez P, Castro-Beiras A. Use of diagnostic and therapeutic resources in patients hospitalized for heart failure: Influence of admission ward type (INCARGAL Study). Rev Esp Cardiol 2003 56 : 49 56.
14. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 2001 37 : 1950 1956.
15. Sachdev M, Sun JL, Tsiatis AA, Nelson CL, Mark DB, Jollis JG. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol 2004 43 : 576 582.
16. Gonzalez-Juanatey JR, Alegria E, Aznar J, Bertomeu-Martinez V, Franch-Nadal J, Palma-Gamiz JL. Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists. Rev Esp Cardiol 2006 59 : 801 806.
17. Heidrich J, Behrens T, Raspe F, Keil U. Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005 12 : 521 529.
18. Mancia G, De BG, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007 28 : 1462 1536.
19. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005 26 : 967 974.
20. Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007 28 : 88 136.
21. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
22. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002 39 : 1 266.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 383.
24. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006 295 : 180 189.
25. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries. Lancet 2001 357 : 995 1001.
26. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004 364 : 937 952.
27. Hossain P, Kawar B, El NM. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007 356 : 213 215.
28. Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007 357 : 1301 1310.
29. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: Meta-analysis of cohort studies. Arch Intern Med 2000 160 : 939 944.
30. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 2008 117 : 1028 1036.